ALLIANCEBERNSTEIN L.P. - BIOHAVEN PHARMACTL HLDG CO L ownership

BIOHAVEN PHARMACTL HLDG CO L's ticker is BHVN and the CUSIP is G11196105. A total of 121 filers reported holding BIOHAVEN PHARMACTL HLDG CO L in Q3 2018. The put-call ratio across all filers is 0.12 and the average weighting 0.6%.

Quarter-by-quarter ownership
ALLIANCEBERNSTEIN L.P. ownership history of BIOHAVEN PHARMACTL HLDG CO L
ValueSharesWeighting
Q3 2022$47,530,000
-7.3%
314,412
-10.6%
0.02%0.0%
Q2 2022$51,272,000
-32.8%
351,877
-45.3%
0.02%
-20.7%
Q1 2022$76,280,000
-52.0%
643,336
-44.3%
0.03%
-48.2%
Q4 2021$159,078,000
+6.4%
1,154,328
+7.3%
0.06%
-5.1%
Q3 2021$149,444,000
+10.0%
1,075,834
-23.2%
0.06%
+7.3%
Q2 2021$135,904,000
+36.5%
1,399,920
-3.9%
0.06%
+25.0%
Q1 2021$99,556,000
-3.6%
1,456,559
+20.9%
0.04%
-10.2%
Q4 2020$103,298,000
+9.6%
1,205,204
-16.8%
0.05%
-3.9%
Q3 2020$94,210,000
+5.8%
1,449,164
+18.9%
0.05%
-1.9%
Q2 2020$89,087,000
+72.7%
1,218,528
-19.6%
0.05%
+40.5%
Q1 2020$51,583,000
-42.2%
1,515,810
-7.5%
0.04%
-27.5%
Q4 2019$89,238,000
+11.9%
1,639,190
-14.2%
0.05%
+2.0%
Q3 2019$79,734,000
+25.0%
1,911,181
+31.2%
0.05%
+28.2%
Q2 2019$63,807,000
-15.3%
1,457,091
-0.4%
0.04%
-20.4%
Q1 2019$75,306,000
+46.4%
1,463,109
+5.2%
0.05%
+28.9%
Q4 2018$51,440,000
-13.6%
1,391,019
-12.2%
0.04%
-2.6%
Q3 2018$59,516,000
-16.4%
1,584,982
-12.0%
0.04%
-22.0%
Q2 2018$71,191,000
+89.5%
1,801,380
+23.5%
0.05%
+85.2%
Q1 2018$37,559,000
-12.9%
1,458,027
-8.7%
0.03%
-12.9%
Q4 2017$43,107,000
+33.4%
1,597,756
+84.9%
0.03%
+29.2%
Q3 2017$32,305,000
+196.9%
864,230
+98.6%
0.02%
+200.0%
Q2 2017$10,880,000435,2090.01%
Other shareholders
BIOHAVEN PHARMACTL HLDG CO L shareholders Q3 2018
NameSharesValueWeighting ↓
Knoll Capital Management, LLC 857,494$29,181,00027.41%
RP Management, LLC 2,111,111$71,841,00022.30%
ORACLE INVESTMENT MANAGEMENT INC 1,870,743$63,661,00018.92%
KINGDON CAPITAL MANAGEMENT, L.L.C. 1,462,761$49,778,0009.11%
Blackcrane Capital, LLC 267,868$9,116,0008.33%
Foresite Capital Management IV, LLC 156,355$5,321,0006.56%
ARS Investment Partners, LLC 603,036$20,521,0004.95%
ARDSLEY ADVISORY PARTNERS LP 371,250$12,608,0004.94%
GREAT POINT PARTNERS LLC 1,000,000$34,030,0003.56%
Foresite Capital Management III, LLC 62,245$2,118,0003.37%
View complete list of BIOHAVEN PHARMACTL HLDG CO L shareholders